IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against Ability Inc. (“Ability” or the “Company”) (NASDAQ: ABIL). Investors who purchased or otherwise acquired shares between September 8, 2015 and April 29, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the
July 25, 2016 lead plaintiff motion deadline.

If you purchased shares of Ability during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that, during the Class Period, Ability issued false and misleading statements and/or failed to disclose that: the Company overstated its income by not accounting for commissions; the Company materially overstated its operating results by improperly recognizing revenue on multiple element sales transactions; Ability has material weaknesses in its internal controls; and as a result of the above, the Company’s financial statements for the years ending December 31, 2013 and 2014 were materially false and misleading, and not prepared in accordance with U.S. Generally Accepted Accounting Principles.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 442760

LOS ANGELES, CA / ACCESSWIRE / July 25, 2016 / Lundin Law PC (the “Firm”) announces that a class action lawsuit was filed against Juno Therapeutics Inc. (“Juno” or the “Company”) (NASDAQ: JUNO) concerning possible violations of federal securities laws between June 4, 2016 and July 7, 2016 (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the September 12, 2016 lead plaintiff motion
deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, the Company failed to disclose that a patient died during a clinical trial for its product candidate in May 2016. Juno was thus trading at artificially inflated prices and some insiders participated in heavy selling of shares until July 7, 2016. On July 7, 2016 the Company announced the May 2016 death and two additional deaths during clinical trial, and the Food & Drug Administration put a hold on the trial. After the release of this news, shares of Juno fell in value significantly.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 442758

IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against Immunomedics Inc. (“Immunomedics” or the “Company”) (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the
August 8, 2016, lead plaintiff motion deadline.

If you purchased shares of Immunomedics during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that Immunomedics issued false and misleading statements to investors and/or failed to disclose: that the Company’s abstract for antibody-drug IMMU-132 submitted to the American Society of Clinical Oncology (ASCO) for presentation at their 2016 Annual Meeting contained previously disclosed results from a mid-stage study; that Immunomedics misrepresented to ASCO that the abstract contained only updated and previously undisclosed data; and that as a result of this ASCO removed the IMMU-132 presentation from the 2016 ASCO Annual Meeting schedule.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 442757

LOS ANGELES, CA / ACCESSWIRE / July 25, 2016 / Lundin Law PC (the “Firm”) announces a class action lawsuit has been filed against Stericycle, Inc. (“Stericycle” or the “Company”) (NASDAQ: SRCL, SRCLP) concerning possible violations of federal securities laws between February 7, 2013 and April 28, 2016 (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the September 12, 2016 lead plaintiff
motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the complaint, the Company failed to disclose that it engaged in a scheme whereby it routinely raised the rates it charged smaller customers in violation of the contracts with those customers. This inflated revenues and growth. On October 22, 2015 the Company announced disappointing growth rates and revenues during the third quarter of 2015. On April 28, 2016 Stericycle disclosed its results for the first quarter of 2016 which were again below expectations. Upon release of this news, the Company’s stock price fell significantly.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 442763

ZURICH, SWITZERLAND / ACCESSWIRE / July 25, 2016 / Today, Stephan Bogner from Rockstone Research published an update on True Leaf Medicine International Ltd. (CSE: MJ). The Chairman of True Leaf Medicine International Ltd., Michael Harcourt, today has sent a letter to all stakeholders bringing up to date on the company’s remarkable achievements over the last 12 months. Since True Leaf went public in February 2015, Harcourt is serving as Chairman, before he was Vancouver’s former Mayor and former Premier of British Columbia.

After a successful market launch recently in Canada, USA and Europe, True Leaf’s hemp-fused dog chews are well received by the market. Chris Parry took his hat off already in May and Rockstone also strongly believes that the company is well on track to become a serious contender in the pet foods industry in North America and Europe, possibly Asia soon as well.

The company appears to be well ahead of the competition as its products take root in each market, a result of being the ‘first mover’ in a huge potential market. Bearing in mind that True Leaf recently just started to sell its products, readers should not expect mammoth revenues to be reported initially. Sales should start to increase significantly as their store penetration increases within their distribution reach and line extensions increase their order book.

The full report can be accessed with the following links:

English (PDF):

http://rockstone-research.com/images/PDF/TrueLeaf17en.pdf

English (Webversion):

http://rockstone-research.com/index.php/en/research-reports/1282-True-Leaf-just-started-to-take-root-(to-grow-big-thereafter)

German (PDF):

http://rockstone-research.com/images/PDF/TrueLeaf17de.pdf

Disclaimer: Please read
the full disclaimer within the full research report as a PDF as fundamental
risks and conflicts of interest exist.

SOURCE: Rockstone Research

ReleaseID: 442782

LAS
VEGAS, NV / ACCESSWIRE / July 25, 2016 / Aristocrat Group Corp. (ASCC) has engaged a Texas liquor wholesaler and shipped its first quantities of RWB Premium Vodka through them, greatly expanding its market in the Lone Star State and making the top-shelf spirit available to a wider array of consumers.

This important move comes as recently released federal beverage statistics show demand for vodka, particularly hand-crafted varieties and premium brands, continues to grow. According to the U.S. Treasury Department’s Alcohol and Tobacco Trade and Tax Bureau, vodka bottled for domestic use rose 7.5 percent year to date in April, 2016 – a rate 1.14 times larger than the bottled growth for domestic use of all distilled spirits.

Sales of premium vodkas, like RWB, easily outpaced all other types of vodkas, jumping more than 11 percent in 2015.

“Consumers these days want quality and these statistics clearly show they’re willing and happy to pay for the finer things, such as hand-crafted spirits like ours,” said ASCC CEO Chris Less. “With our new wholesaler now in place, we’re poised to take full advantage of this increasing demand for quality. We’re more solidly integrated in our core market and also in a strong position to develop new ones. With increased distribution and availability, more people can discover what sets our brand apart.”

For more information, please visit www.aristocratgroupco.com/aristocratgroupco_com/investors.html.

About
the Aristocrat Group Corp.

The Aristocrat Group Corp. (ASCC) identifies and promotes unique brands that have mass market appeal across diverse demographics. ASCC’s brand management includes premium luxury goods, including top-shelf distilled spirits like RWB Vodka. The Company targeted the growing market for quality domestic spirits in order to deliver maximum returns to its shareholders. ASCC, which hopes to capitalize on unprecedented new brand-building opportunities, is working to build a portfolio of successful brands to compete in a highly profitable sector alongside LVMH Moet Hennessy Louis Vuitton (NASDAQ:LVMUY), Diageo PLC (NYSE:DEO), and Brown-Forman Corp. (NYSE:BF-B).

For more information about the Aristocrat Group Corp., visit www.aristocratgroupco.com/aristocratgroupco_com/investors.html.

For more information on Ultra-Premium Handcrafted RWB Vodka, please visit www.rwbvodkaco.com.

Notice
Regarding Forward-Looking Statements

Safe
Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:

Aristocrat Group Corp.

Chris Less, President
702-761-6866
info@aristocratgroupcorp.com

Source: Aristocrat Group Corp.

ReleaseID: 442764

VANCOUVER, BC / ACCESSWIRE / July 25, 2016 / Cruz Capital Corp (TSXV: CUZ) (OTC: BKTPF) has entered into a share purchase agreement with Cobalt Locaters Inc. The assets of Cobalt Locaters Inc. consist of 6 separate cobalt prospects. 4 are located in Ontario and 2 are in British Columbia. Cruz will now hold 7 separate cobalt prospects in Canada.

Jim Nelson, President of Cruz Capital states, “We are extremely pleased to be able to acquire, within one transaction, what we feel is the best set of underdeveloped cobalt-first assets situated in Canada. Management’s plan would be to further these prospects along and either develop them internally or look to joint venture them. We believe we are at the earliest stages of a significant Cobalt boom and we feel all these assets in one company will put Cruz at the forefront of this exploding sector. Cruz has a tight share structure with only approximately 8 million shares outstanding after this transaction. Our goal is to make Cruz into the premier cobalt asset project generator in North America.”

According to a MetalBulletin story dated July 18, 2016, “…Cobalt metal prices have been rising in recent weeks on the positive sentiment created by strong forward demand from the super-alloys sector as well as the anticipation of higher prices that has resulted from an expected surge in production of electric vehicles.” The cobalt price has recently traded to a 6 month high.

To view an enhanced version of this image, please visit:

https://orders.newsfilecorp.com/files/4754/21758_cruz.h2.jpg

According to an interview with Chris Berry of House Mountain Partners on June 20, 2016 he states “…I think one of the things that’s surprised me is how most people haven’t woken up to the opportunity. Again, we can get into a lot of the details about battery and battery metals and how important lithium is, or cobalt is or graphite is, but I think cobalt is really sort of an undiscovered opportunity right now and hopefully that will change soon.”

The acquisition terms to acquire Cobalt Locaters Inc are cash of $20,000 and the issuance of 1,600,000 shares of the Company to four arm’s length parties. Cruz’s 2 BC properties are 100% owned and the 4 Ontario prospects are 50%. The acquisition is subject to execution of formal documentation and TSX Venture approval.

Cruz has also granted 500,000 incentive stock options to directors, officers and consultants at an exercise price of .35 cents per share for six months. The options have been granted in accordance with the company’s stock option plan.

Greg Thomson PGeo has reviewed this news release.

If you would like to be added to Cruz’s email list please send an email to info@cruzcapitalcorp.com or twitter @CruzCapitalCorp

James Nelson
President
604.899.9150
www.cruzcapitalcorp.com
twitter @CruzCapitalCorp

SOURCE: Cruz Capital Corp

ReleaseID: 442780